TSX News -
Spectral to File Final PMA Module With the FDA for Its Toraymyxin(TM) Treatment of Endotoxemic Septic Shock
TORONTO, ONTARIO–(Marketwired – Feb. 23, 2017) – Spectral Medical Inc., (“Spectral” or the “Company”), (TSX:EDT) a Phase III company developing […]